Essence Group, a leading technology group developing and supplying wireless, cloud-based security and senior care solutions, ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today issued ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing ...

Linus Health Drives the Next Era of Early Brain Health Detection Expanding adoption, evidence, and innovation to support ...

Some time around 1683, amateur Dutch scientist Antonie van Leeuwenhoek scraped the plaque from between his teeth and peered ...

National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced changes in leadership across multiple ...

Learn more about the gene linked to the evolutionary loss of human tails, and how, in rare cases, some people are still born ...

Pathologic 3's time travel format might seem to diminish Pathologic's challenges, but is actually a new and diseased way of ...

Imagine going to the hospital for a bacterial ear infection and hearing your doctor say, "We're out of options." It may sound ...

Heartworm disease is caused by the parasite Dirofilaria immitis. It is spread to dogs by mosquitoes and can be fatal. Adult ...

Enterprise imaging has become one of the fastest-growing sources of healthcare data, driven by the expansion of AI-enabled diagnostics, larger imaging file sizes, and increased utilization across care ...

Amber Implants, a Netherlands medtech developing next-generation implants for spinal injuries, named Vincent Gardès as CEO.